We were honored to participate in the RCOG Exhibition in Oman, where we had the opportunity to showcase cutting-edge advancements in genetic testing and healthcare solutions
17
Oct
Oct
Category Archives: News
26
Sep
Sep
Certain risk factors increase the likelihood of women developing breast cancer at a younger age
14
Mar
Mar
At the forefront of cutting-edge medical research is the field of genetics. With the ability to analyze genetic data and develop personalized treatment plans, genetic laboratories play a vital role in advancing knowledge of genetic diseases and improving patient outcomes. At our genetic laboratory, we are dedicated to making a difference in the lives of …
News
FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions
17
Aug
Aug
Today, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions. “Today’s approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing red blood cell transfusions,” said …
Life can change dramatically when someone learns they are genetically predisposed to a disease, such as a condition called familial hypercholesterolemia, where a mutated gene can lead to elevated cholesterol and increased risk for a premature heart attack. But these kinds of disease predictions are complicated: not everyone carrying such high-risk single-gene variants develops the …
BY ROBERT PREIDT, HealthDay Reporter It may be possible to protect Parkinson’s patients’ brains from further damage by turning off a “master regulator” gene, researchers report. “One of the biggest challenges in treating Parkinson’s, other than the lack of therapies that impede disease progression, is that the disease has already laid waste to significant portions of …
As scientists scramble to learn more about the SARS-CoV-2 coronavirus, two recent studies of the virus’ genome reached controversial conclusions: namely, that snakes are intermediate hosts of the new virus, and that a key coronavirus protein shares “uncanny similarities” with an HIV-1 protein. Now, a study in ACS’ Journal of Proteome Research refutes both ideas and suggests …
29
Mar
Mar
Thirty thousand base pairs make up the (relatively tiny) SARS-CoV-2 genome. A singular genome holds limited information. But, by comparing multiple genomes from different patients, animals, places, or time periods, the DNA’s information can be unlocked. From where the virus originated to how it spilled over from animals into humans, how quickly it mutates, and …
26
Mar
Mar
The U.K. has a plan to sequence and analyze the genetic code of SARS-CoV-2 from as many COVID-19 samples as they can. Scientists, clinicians, academic institutions, and the government have joined together in a massive collaboration to create a map of COVID-19 spread based on whole-genome sequencing. This effort, named the COVID-19 Genomics UK Consortium …
26
Mar
Mar
The list of compounds that could make an effective COVID-19 treatment grows longer each day. The latest to join the ranks, EIDD-2801, shows notable promise in becoming a weapon in the fight against SARS-CoV-2 and has infused new hope into the search for a possible therapeutic for COVID-19. A description of the efficacy of EIDD-2801 …
- 1
- 2